Prospective study of bezafibrate for post operated bilirary atresia
Biliary Atresia Obstructive jaundice;D001656
Bezafibrate 400 mg/day is orally administered to patients after biliary atresia in two divided doses after breakfast and dinner. Bezafibrate400 mg/day is orally administered to patients after biliary atresia in two divided doses ...